IL159343A0 - Preparation of flumethasone and its 17-carboxyl androsten analogue - Google Patents

Preparation of flumethasone and its 17-carboxyl androsten analogue

Info

Publication number
IL159343A0
IL159343A0 IL15934302A IL15934302A IL159343A0 IL 159343 A0 IL159343 A0 IL 159343A0 IL 15934302 A IL15934302 A IL 15934302A IL 15934302 A IL15934302 A IL 15934302A IL 159343 A0 IL159343 A0 IL 159343A0
Authority
IL
Israel
Prior art keywords
flumethasone
acetate
preparation
6alpha
16alpha
Prior art date
Application number
IL15934302A
Other languages
English (en)
Original Assignee
Hovione Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20086054&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL159343(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hovione Ltd filed Critical Hovione Ltd
Publication of IL159343A0 publication Critical patent/IL159343A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
    • C07J3/005—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom the carbon atom being part of a carboxylic function
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C07J71/0015—Oxiranes at position 9(11)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Control Of Combustion (AREA)
  • Reduction Or Emphasis Of Bandwidth Of Signals (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
IL15934302A 2001-06-12 2002-06-11 Preparation of flumethasone and its 17-carboxyl androsten analogue IL159343A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PT102628A PT102628B (pt) 2001-06-12 2001-06-12 Novo processo de preparação de flumetasona e do seu análogo 17-carboxilo androsteno
PCT/GB2002/002644 WO2002100878A1 (en) 2001-06-12 2002-06-11 Preparation of flumethasone and its 17-carboxyl androsten analogue

Publications (1)

Publication Number Publication Date
IL159343A0 true IL159343A0 (en) 2004-06-01

Family

ID=20086054

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15934302A IL159343A0 (en) 2001-06-12 2002-06-11 Preparation of flumethasone and its 17-carboxyl androsten analogue
IL159343A IL159343A (en) 2001-06-12 2003-12-11 Preparation of flumethasone and its 17 - carboxyl androsten analogue

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL159343A IL159343A (en) 2001-06-12 2003-12-11 Preparation of flumethasone and its 17 - carboxyl androsten analogue

Country Status (19)

Country Link
US (1) US6528666B1 (pt)
EP (1) EP1395603B1 (pt)
JP (1) JP4095018B2 (pt)
CN (1) CN1244593C (pt)
AT (1) ATE460422T1 (pt)
AU (1) AU2002310616B2 (pt)
CA (1) CA2450661C (pt)
CY (1) CY1109960T1 (pt)
DE (1) DE60235625D1 (pt)
DK (1) DK1395603T3 (pt)
ES (1) ES2338768T3 (pt)
IL (2) IL159343A0 (pt)
NO (1) NO326153B1 (pt)
NZ (1) NZ530536A (pt)
PL (1) PL206731B1 (pt)
PT (1) PT102628B (pt)
RU (1) RU2260596C1 (pt)
WO (1) WO2002100878A1 (pt)
ZA (1) ZA200309656B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7098328B2 (en) * 2001-11-29 2006-08-29 Taro Pharmaceutical Industries Limited Method for the preparation of 6α-fluoro corticosteroids
ATE318274T1 (de) * 2002-12-09 2006-03-15 Sicor Inc Prozess zur herstellung von 6 alpa-fluorierten pregnanen
EP1526139A1 (en) * 2003-10-24 2005-04-27 S.N.I.F.F. Italia S.P.A. A process for preparing highly pure androstane 17-beta-carboxylic acids and androstane 17-beta-carbothioic acid fluoromethyl esters
CN100429221C (zh) * 2005-10-31 2008-10-29 浙江仙琚制药股份有限公司 皮质激素的合成方法
CN101759761B (zh) * 2008-11-28 2012-08-08 天津金耀集团有限公司 含有6α-F的甾体化合物的制备方法
EP2386634A4 (en) 2009-01-07 2012-07-18 Mitsubishi Chem Corp ENZYMATIC STEROL LATERAL CHAIN CLEAVAGE PROTEIN AND USE THEREOF
CN101942002A (zh) * 2010-09-24 2011-01-12 岳阳环宇药业有限公司 一种甾体21位酯化物的精制工艺
ITMI20122200A1 (it) * 2012-12-20 2014-06-21 Trifarma Spa Processo per la preparazione di 6-alfa-fluoro pregnani
RU2532902C1 (ru) * 2013-07-12 2014-11-20 Российская Федерация, от имени которой выступает Министерство промышленности и торговли Российской Федерации (Минпромторг России) Способ получения 11бета, 17альфа, 21-тригидрокси-16альфа-метил-9альфа-фторпрегна-1,4-диен-3,20-диона (дексаметазона) из фитостерина

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3499016A (en) 1958-08-04 1970-03-03 Upjohn Co 6alpha-fluoro-16alpha-methyl derivatives of the pregnane series
US3636010A (en) 1968-12-23 1972-01-18 Ciba Geigy Corp Esters of steroid-17-carboxylic acids
NL187577C (nl) * 1978-04-05 1991-11-18 Sibla Srl 3-acetoxy-9beta,11beta-epoxy-pregna-1,3,5-trienen, werkwijze voor de bereiding daarvan en werkwijze voor de bereiding van 6alfa-halogeen-pregna-1,4-dieen-3-onen.
US4188322A (en) * 1978-04-28 1980-02-12 Blasinachim S.P.A. Process for the preparation of 6-halo-pregnanes
FR2701262B1 (fr) 1993-02-05 1995-03-24 Roussel Uclaf Nouveau procédé de préparation de stéroïdes 6 alpa, 9 alpha-difluorés et nouveaus intermédiaires.
IT1319663B1 (it) * 2000-11-17 2003-10-23 Farmabios Srl Processo per la preparazione di fluoro-steroidi.

Also Published As

Publication number Publication date
ATE460422T1 (de) 2010-03-15
ES2338768T3 (es) 2010-05-12
EP1395603A1 (en) 2004-03-10
DE60235625D1 (de) 2010-04-22
CN1531544A (zh) 2004-09-22
NZ530536A (en) 2005-05-27
PT102628A (pt) 2002-12-31
WO2002100878A1 (en) 2002-12-19
RU2004100309A (ru) 2005-07-10
CN1244593C (zh) 2006-03-08
PL367843A1 (en) 2005-03-07
NO326153B1 (no) 2008-10-06
JP2004534795A (ja) 2004-11-18
AU2002310616B2 (en) 2007-08-30
CA2450661C (en) 2008-01-08
US6528666B1 (en) 2003-03-04
DK1395603T3 (da) 2010-05-10
CY1109960T1 (el) 2014-09-10
EP1395603B1 (en) 2010-03-10
IL159343A (en) 2010-11-30
ZA200309656B (en) 2004-06-22
PL206731B1 (pl) 2010-09-30
CA2450661A1 (en) 2002-12-19
RU2260596C1 (ru) 2005-09-20
PT102628B (pt) 2010-09-09
AU2002310616A2 (en) 2002-12-23
NO20035517D0 (no) 2003-12-11
JP4095018B2 (ja) 2008-06-04

Similar Documents

Publication Publication Date Title
CY1109960T1 (el) Παρασκευη φλουμεθαζονης και του αναλογου αυτης17-καρβοξυλο-ανδροστενιου
NO164905C (no) Fremgangsmaate for fremstilling av 16,17-acetal-pregnanderivater.
AU649472B2 (en) New pregna-1,4-diene-3,20-dione-16-17-acetal-21 esters, process for their preparation, compositions and method for the treatment of inflammatory conditions
WO2004002404A3 (en) Compositions and method for enhanced mucosal delivery of interferon beta
HK1082682A1 (en) Pharmaceutical composition
HU9200048D0 (en) Process for treating androgene deseases
HUP9903747A2 (hu) Új eljárás mometazon-furoát előállítására
GR3021436T3 (en) New process for the production of 11-keto steroids
IL164159A0 (en) C-17 spirolactonization and 6,7 oxidation of steroids
HK1058043A1 (en) Process for the production of 16,17-[(cyclohexylmethylen)bis(oxy)]-11,21- dihydroxy-pregna-1,4-dien-3,20-dion or its 21-isobutyrat by transketalisation ;
MY136880A (en) Piperazinyl-or piperidinylamine-sulfamic acid amides as inhibitors of steroid sulfatase
HRP20031068A2 (en) Chloromethylation of thiophene
AU571073B2 (en) Pharmaceutical composition of 9a, 11b-dichcoro-16a-methl-21-oxycarbonyl dicyclohexycmethycoxy pregna-1,4-diene-3,20-dione
Henley et al. EFFECT OF IONIZING RADIATION ON AQUEOUS ETHYLENE OXYGEN SOLUTIONS
GB1367928A (en) Halogenopregnadiene and process for its manufacture
IT1302657B1 (it) Processo stereoselettivo per la preparazione di budesonide nella formadi epimero 22-r.
Moriwaki et al. Treatment of Subglottic Stenosis
GB1064078A (en) 5-a-pregnano-[3,2-c]pyrazole compounds
GB979769A (en) 16ª‰-acetyl-3:20-diketosteroids,their manufacture and use
GB935317A (en) 2, 3-diketo-5ªá-steroids
GB978725A (en) Novel steroid compounds and processes for their perparation
IT1247692B (it) 6 fluoro 6 metilpregn-4-ene-3,20 dioni e 6-fluoro-6-metilpregna-l, 4-diene-3,20-dioni,procedimento per la loro preparazione e composizioni farmaceutiche ad attivita' anti-infiammatoria che li contengono
GB888165A (en) Improvements in or relating to 4-methyl-3-oxo-í~-steroids
DK0647235T3 (da) Fremgangsmåde til steroide peracylglycosider
EP0866798A4 (en) PRESENTATION OF ESTER DERIVATIVES OF STEROIDS